The work of Libman and Sacks, who correlated the cutaneous lesions of acute disseminated ... reticulum-cell sarcoma, giant-follicular lymphoma, chloroma and Spiegler-Fendt sarcoid.

For evaluating response to treatment for follicular lymphoma, computed tomography ... “When assessed with contrast-enhanced CT, these residual lesions will be considered as residual disease ...

Novartis' CAR-T Kymriah has become the first therapy in the category to be approved for the treatment of relapsed/refractory follicular lymphoma, ahead of Gilead Sciences' rival Yescarta.